BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 12502815)

  • 1. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.
    Hsu M; Harouse JM; Gettie A; Buckner C; Blanchard J; Cheng-Mayer C
    J Virol; 2003 Jan; 77(2):989-98. PubMed ID: 12502815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of quasispecies diversity but no evidence for adaptive evolution of SHIV during rapid serial transfers among seronegative macaques.
    Balfe P; Shapiro S; Hsu M; Buckner C; Harouse JM; Cheng-Mayer C
    Virology; 2004 Jan; 318(1):267-79. PubMed ID: 14972553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques.
    Himathongkham S; Halpin NS; Li J; Stout MW; Miller CJ; Luciw PA
    J Virol; 2000 Sep; 74(17):7851-60. PubMed ID: 10933692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
    Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
    J Virol; 2001 Jun; 75(12):5646-55. PubMed ID: 11356972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the basis of CD4(+) T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
    Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
    Vaccine; 2002 May; 20(15):1934-7. PubMed ID: 11983249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
    Igarashi T; Donau OK; Imamichi H; Dumaurier MJ; Sadjadpour R; Plishka RJ; Buckler-White A; Buckler C; Suffredini AF; Lane HC; Moore JP; Martin MA
    J Virol; 2003 Dec; 77(24):13042-52. PubMed ID: 14645561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of a simian-human immunodeficiency virus strain resistant to a vaginal microbicide in macaques.
    Dudley DM; Wentzel JL; Lalonde MS; Veazey RS; Arts EJ
    J Virol; 2009 May; 83(10):5067-76. PubMed ID: 19279098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
    Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
    J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3).
    Harouse JM; Gettie A; Eshetu T; Tan RC; Bohm R; Blanchard J; Baskin G; Cheng-Mayer C
    J Virol; 2001 Feb; 75(4):1990-5. PubMed ID: 11160699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Envelope glycoprotein determinants of increased entry in a pathogenic simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) passaged in monkeys.
    Si Z; Gorry P; Babcock G; Owens CM; Cayabyab M; Phan N; Sodroski J
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):163-73. PubMed ID: 15018704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1.
    Lue J; Hsu M; Yang D; Marx P; Chen Z; Cheng-Mayer C
    J Virol; 2002 Oct; 76(20):10299-306. PubMed ID: 12239306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones.
    Chakrabarti LA; Ivanovic T; Cheng-Mayer C
    J Virol; 2002 Feb; 76(4):1588-99. PubMed ID: 11799153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.
    Ren W; Mumbauer A; Zhuang K; Harbison C; Knight H; Westmoreland S; Gettie A; Blanchard J; Cheng-Mayer C
    Retrovirology; 2013 Jan; 10():9. PubMed ID: 23369442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying
    Scinto HB; Gupta S; Thorat S; Mukhtar MM; Griffiths A; Delgado J; Plake E; Vyas HK; Strickland A; Byrareddy SN; Montefiori DC; LaBranche C; Pal R; Treece J; Orndorff S; Ferrari MG; Weiss D; Chenine AL; McLinden R; Michael N; Kim JH; Robb ML; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Ruprecht RM
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
    Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic determinants of the mucosally transmissible CXCR4-specific SHIV(SF33A2) map to env region.
    Harouse JM; Gettie A; Tan RC; Eshetu T; Ratterree M; Blanchard J; Cheng-Mayer C
    J Acquir Immune Defic Syndr; 2001 Jul; 27(3):222-8. PubMed ID: 11464140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.
    Reimann KA; Li JT; Veazey R; Halloran M; Park IW; Karlsson GB; Sodroski J; Letvin NL
    J Virol; 1996 Oct; 70(10):6922-8. PubMed ID: 8794335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and characterization of a new simian/human immunodeficiency viruses clone carrying an env gene derived from a CRF07_BC strain.
    Li Y; Yang GB; Chen QM; Liu Q; Meng ZF; Geng YQ; Qiao WT; Shao YM
    Chin Med J (Engl); 2009 Dec; 122(23):2874-9. PubMed ID: 20092794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2).
    Cayabyab M; Karlsson GB; Etemad-Moghadam BA; Hofmann W; Steenbeke T; Halloran M; Fanton JW; Axthelm MK; Letvin NL; Sodroski JG
    J Virol; 1999 Feb; 73(2):976-84. PubMed ID: 9882298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.